CERo Therapeutics Holdings, Inc. (CERO) stock
CEROOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CEROW
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $253.05KP/E –Yield 172833.33%
CERo Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
CERo Therapeutics's enterprise value was -$789.50K on Apr 30, 2024.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2024 | Apr 30, 2024 | -$789.50K | – |
See a number that looks wrong?